New Study: Chemo Before Surgery Avoids Need for Mastectomy for Many with Triple-Negative Breast Cancer

Chemotherapy before surgery shrank triple-negative breast tumors in women in a clinical trial to the point where half of those who had not been eligible for breast-conserving surgery became eligible for it, according to investigators at Dana-Farber and Brigham and Women’s Hospital. The findings were reported at the American Surgical Association annual meeting and in … Read more

What Is Waldenström’s Macroglobulinemia?

Waldenström’s macroglobulinemia (Waldenström’s) is a slow-growing type of non-Hodgkin lymphoma marked by abnormal levels of an antibody called macroglobulin (IgM). Also known as lymphoplasmacytic lymphoma, Waldenström’s mostly forms in the bone marrow and can hinder the growth of normal blood cells, which can lead to anemia as well as a weakened immune system. Waldenström’s sometimes … Read more

What’s New in Skin Cancer Research?

Although malignant melanoma has been attracting much of the media spotlight because of promising new immunotherapy drugs, advances are also being made in other types of skin cancer. Nonmelanoma skin cancers, such as basal cell carcinoma and squamous cell carcinoma, are very common, with more than 3.5 million cases diagnosed annually. In fact, it’s estimated … Read more

New Treatment Option for Patients with Rare Blood Cancer

It’s commonly thought that targeted therapy for cancer requires the development of separate drugs for each type and subtype of cancer. The recent approval of the drug ibrutinib (Imbruvica®), however, for Waldenström’s macroglobulinemia (a rare form of lymphoma) shows the opposite to be true: a single agent can be effective against multiple types of cancers, providing … Read more

FDA Approves New Therapy for Metastatic Breast Cancer

The U.S. Food and Drug Administration has approved a new treatment  for women with advanced (metastatic) breast cancer. The new therapy, palbociclib, will be used to treat postmenopausal women with metastatic estrogen receptor-positive (ER-positive) breast cancer who have not received previous treatment. Palbociclib, which is marketed under the name Ibrance, will be used in combination … Read more

New Drug Combination Shows Promise for Women with Recurrent Ovarian Cancer

For many women with ovarian cancer that has returned after initial treatment, a two-drug combination can significantly extend the time that the disease is kept in check, according to a phase 2 clinical trial led by investigators at the Susan F. Smith Center for Women’s Cancers at Dana-Farber. As reported in Lancet Oncology, researchers compared … Read more

What Is Merkel Cell Carcinoma?

Merkel cells are found just below your skin’s surface, on the lowest level of your top layer of skin (the epidermis). Connected to nerve endings associated with the sensation of pressure, Merkel cells play a key role in helping us identify fine details and textures by touch.  What is Merkel cell carcinoma?  Merkel cell carcinoma is … Read more

What is Liposarcoma?

Cancers known as sarcomas develop in the connective tissues, such as muscle, fat, and bone, that hold the body together. The type of sarcoma called liposarcoma originates in fat cells that have been driven by random DNA errors into malignant growth, forming tumors. George Demetri, MD, director of Dana-Farber’s Center for Sarcoma and Bone Oncology, … Read more